These epigenetic alterations align with functional studies indicating that reduced methylation at intron 1 increases SNCA expression, and have been associated with earlier onset and more rapid progression of PD (Fedotova et al., 2023; Jowaed et al., 2010). This evidence concerns the gene SNCA and Parkinson disease.